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 The National Early Warning Score 2 (NEWS2) 
 Editor – Hodgson  et al 1 demonstrate that the recent modification 
of the National Early Warning Score (NEWS) – NEWS2 – prove 
less sensitive than NEWS in identifying in-hospital death 
for patients with acute exacerbations of chronic obstructive 
pulmonary disease (AECOPD). Professor Williams argues that 
Hodgson  et al have misapplied the NEWS2 SpO 2 scale ( SpO 2 
scale 2 ) to all patients with AECOPD, 2 rather than employing 
it only in those with confirmed hypercapnic respiratory failure 
(HCRF) as recommended. 3 Williams suggests Hodgson's study 
highlights the need for ‘further education’ to avoid improper 
use of NEWS2 in patients without HCRF, implying that if training 
is not undertaken NEWS2 will create a risk for such patients. 
This risk might be worthwhile if NEWS2 performed better than 
NEWS in patients with HCRF. However, in another study of 
NEWS2, 4 we evaluated  SpO 2 scale 2 in patients with/without 
HCRF. We observed reduced sensitivity for in-hospital mortality 
compared to NEWS for patients in two groups – those with 
confirmed HCRF and those at risk of HCRF (eg patients with 
chronic lung disease). Importantly, if used in error in patients 
not at risk of HCRF, NEWS2 generally reduces discrimination 
compared to NEWS. 
 We agree with Hodgson  et al that  SpO 2 scale 2 might be 
applied in error to other patient groups (eg those admitted 
with AECOPD, but without HCRF) when NEWS2 is implemented 
across hospitals and ambulance trusts. While the NEWS2 
recommendations 3 are clear that HCRF should first be 
confirmed before using  SpO 2 scale 2 , the British Thoracic Society 
recommendations state that
 For most patients with known COPD or other known risk factors 
for hypercapnic respiratory failure … a target saturation range 
of 88–92% is suggested pending the availability of blood gas 
results … 5 
 This presents a dilemma, especially for ambulance staff, 
regarding whether to initially titrate oxygen therapy to maintain 
saturations of 88–92% for all patients  at risk of HCRF, or to wait 
until HCRF is confirmed. 
 As Hodgson  et al suggest, this conflict could be addressed by 
further exploration of the relationship between oxygen therapy, 
oxygen saturations and the risk of adverse outcomes. Currently, 
the only studies comparing the performance of NEWS2 and 
NEWS 1,4 suggest that the added complexity of NEWS2 is unlikely 
to be offset by significant benefit to patients and might lead to 
harm. As NEWS2 is now mandated by NHS England, 6 prospective 
evaluation of its application in the ‘real world’ must be urgently 
and carefully conducted. ■ 
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